In detail, luminal A and B breast cancer patients displayed the highest ERBB3 mRNA levels, HER2-enriched and normal-like breast cancer patients showed intermediate levels and basal-like breast cancer patients exhibited the lowest levels. Here, ERBB3 is linked to breast carcinoma.